![](/img/cover-not-exists.png)
Cost-effectiveness projections of oxaliplatin and infusional fluorouracil versus irinotecan and bolus fluorouracil in first-line therapy for metastatic colorectal carcinoma
Bruce E. Hillner, Deborah Schrag, Daniel J. Sargent, Charles S. Fuchs, Richard M. GoldbergVolume:
104
Year:
2005
Language:
english
Pages:
14
DOI:
10.1002/cncr.21411
File:
PDF, 209 KB
english, 2005